AU2540499A - Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content - Google Patents
Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient contentInfo
- Publication number
- AU2540499A AU2540499A AU25404/99A AU2540499A AU2540499A AU 2540499 A AU2540499 A AU 2540499A AU 25404/99 A AU25404/99 A AU 25404/99A AU 2540499 A AU2540499 A AU 2540499A AU 2540499 A AU2540499 A AU 2540499A
- Authority
- AU
- Australia
- Prior art keywords
- active ingredient
- pharmaceutical compositions
- controlled release
- potassium chloride
- ingredient content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 239000008188 pellet Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 235000011164 potassium chloride Nutrition 0.000 title 1
- 239000001103 potassium chloride Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9800369 | 1998-02-20 | ||
HU9800369A HU221435B (en) | 1998-02-20 | 1998-02-20 | Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production |
PCT/HU1999/000013 WO1999042087A2 (en) | 1998-02-20 | 1999-02-19 | Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2540499A true AU2540499A (en) | 1999-09-06 |
Family
ID=89996172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25404/99A Abandoned AU2540499A (en) | 1998-02-20 | 1999-02-19 | Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU2540499A (sk) |
CZ (1) | CZ299182B6 (sk) |
HU (1) | HU221435B (sk) |
PL (1) | PL193028B1 (sk) |
SK (1) | SK287281B6 (sk) |
WO (1) | WO1999042087A2 (sk) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19928312A1 (de) * | 1999-06-16 | 2000-12-21 | Schering Ag | Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe |
DE10347242A1 (de) | 2003-10-10 | 2005-05-04 | Wella Ag | Farbstoffhaltige Pellets zum Färben von Keratinfasern |
EP2023903B1 (en) * | 2006-05-19 | 2014-04-23 | EGIS Gyógyszergyár Nyilvánosan Müködõ Részvénytársaság | Process for the preparation and surface coating of pellets |
DE102008063800A1 (de) | 2008-12-19 | 2010-06-24 | Henkel Ag & Co. Kgaa | Beschichtete Färbemittel |
CN102961363B (zh) * | 2012-12-14 | 2014-09-17 | 河南中帅医药科技股份有限公司 | 氯化钾缓释胶囊 |
ES2725009T3 (es) | 2016-03-04 | 2019-09-18 | Laboratorio Reig Jofre S A | Comprimidos con un alto contenido de principios activos útiles para el tratamiento de la pérdida de cabello o la estimulación de su crecimiento |
EP4308286A1 (de) | 2021-03-16 | 2024-01-24 | Symrise AG | Wirkstoffkapseln |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0052075A1 (de) * | 1980-11-12 | 1982-05-19 | Ciba-Geigy Ag | Körnige Arzneimittel-Retardform |
HU187215B (en) * | 1983-01-26 | 1985-11-28 | Egyt Gyogyszervegyeszeti Gyar | Method for producing pharmaceutical product of high actor content and prolonged effect |
CH658188A5 (de) * | 1984-03-23 | 1986-10-31 | Ciba Geigy Ag | Lagerstabile schnellzerfallende pharmazeutische presslinge. |
US5397574A (en) * | 1993-10-04 | 1995-03-14 | Andrx Pharmaceuticals, Inc. | Controlled release potassium dosage form |
-
1998
- 1998-02-20 HU HU9800369A patent/HU221435B/hu unknown
-
1999
- 1999-02-19 SK SK1188-2000A patent/SK287281B6/sk not_active IP Right Cessation
- 1999-02-19 WO PCT/HU1999/000013 patent/WO1999042087A2/en active IP Right Grant
- 1999-02-19 AU AU25404/99A patent/AU2540499A/en not_active Abandoned
- 1999-02-19 PL PL343268A patent/PL193028B1/pl unknown
- 1999-02-19 CZ CZ20002858A patent/CZ299182B6/cs not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SK287281B6 (sk) | 2010-05-07 |
HUP9800369A1 (hu) | 2000-08-28 |
HU221435B (en) | 2002-10-28 |
WO1999042087A2 (en) | 1999-08-26 |
WO1999042087A3 (en) | 1999-11-25 |
PL343268A1 (en) | 2001-08-13 |
CZ299182B6 (cs) | 2008-05-14 |
CZ20002858A3 (cs) | 2001-01-17 |
PL193028B1 (pl) | 2007-01-31 |
HU9800369D0 (en) | 1998-04-28 |
SK11882000A3 (sk) | 2001-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1689599A (en) | Sustained release medicinal compositions | |
AU4338099A (en) | Pharmaceutical composition containing a salt of acetaminophen and at least one other active ingredient | |
EP1001813B8 (en) | Pharmaceutical formulations containing voriconazole | |
AU3977099A (en) | Controlled release oral dosage form | |
AU2300699A (en) | Amidino derivatives and drugs containing the same as the active ingredient | |
AU4413299A (en) | Stabilized pharmaceutical compositions | |
AU3192700A (en) | Medicinal compositions | |
AU6740298A (en) | Pharmaceutical composition | |
AU1574900A (en) | Pharmaceutical compositions containing insulin | |
HU9802795D0 (en) | Pharmaceutical compositions containing more active components | |
AU2005300A (en) | Medicinal compositions | |
AU2003240654A1 (en) | Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release | |
AU8107998A (en) | Pharmaceutical compositions | |
AU6309698A (en) | Drugs containing aminopyridine derivatives as the active ingredient | |
AU4779399A (en) | Pharmaceutical levothyroxine preparation | |
HUP0102894A3 (en) | A substituted triazolo-pyridazine derivative, pharmaceutical compositions containing them | |
AU5965399A (en) | Pharmaceutically active composition | |
AU2002340573A1 (en) | Powdery active ingredient formulations | |
AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
PL327567A1 (en) | Prolonged release granules containing dilthiazem as their active ingredient | |
AU2540499A (en) | Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content | |
AU2080695A (en) | Pharmaceutical inhalation compositions containing a solid active ingredient | |
AU4317500A (en) | Antibiral compositions containing phorbol derivatives as the main active ingredient | |
AU9343098A (en) | Pharmaceutical composition | |
AU1930097A (en) | Slow-release pharmaceutical formulations containing mizolastin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |